Atrial Fibrillation
Conditions
Interventions
ablation for combining focal activation and stable high-frequent activity using continuous wavelet transform analysis
no ablation for combining focal activation and stable high-frequent activity using
Sponsors
Tohoku Medical and Pharmaceutical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients diagnosed with non-valvular persistent atrial fibrillation who are able to attend regular outpatient visits. (2) Patients aged 20 years or older at the time of obtaining consent (regardless of sex). (3) Patients who have provided written informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with a confirmed diagnosis of mitral stenosis. (2) Patients with prosthetic heart valves (mechanical or bioprosthetic). (3) Patients who have experienced a cardiovascular event (stroke, myocardial infarction, non-infarction cardiac intervention, or heart failure requiring hospitalization) or bleeding requiring hospitalization within one month prior to enrollment. (4) Patients diagnosed with a life expectancy of less than one year due to any disease. (5) Patients with left atrial thrombus. (6) Patients with a left atrial diameter greater than 55 mm. (7) Patients with a history of catheter ablation. (8) Patients unable to continue anticoagulant therapy. (9) Pregnant patients. (10) Patients with thyroid dysfunction requiring treatment. (11) Patients with active malignancy. (12) Patients deemed unsuitable for participation in the study by the attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is the absence of atrial fibrillation without the use of antiarrhythmic drugs for one year after the procedure. | — |
Countries
Japan
Contacts
Public ContactKoji Kumagai
Tohoku Medical and Pharmaceutical University Department of Cardiovascular Medicine
Outcome results
None listed